Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Medical Genetics · Transcobalamin II Deficiency

The Genetics and Biological "Mirrors" of TCII Deficiency

At a Glance

TCII deficiency is an inherited TCN2 transport disorder: vitamin B12 can be normal or high in the blood while cells cannot receive enough. Genetic and biochemical testing helps distinguish it from maternal B12 deficiency, bone marrow disorders, and severe immune deficiency.

Understanding the biology of Transcobalamin II (TCII) deficiency helps explain why your child’s body is acting the way it is. This condition is not a simple vitamin deficiency caused by diet; it is a genetic “transport” problem that changes how the body moves Vitamin B12 from the blood into the cells where it is needed [1][2].

The Role of the TCN2 Gene

The instructions for building the TCII protein are found in the TCN2 gene [3]. Normally, this gene produces the TCII “taxi” protein that picks up Vitamin B12 in the bloodstream. Once the taxi has its passenger (B12), it travels to a cell, docks at a specific “loading bay” (a receptor called CD320), and is pulled inside [4][1].

In children with TCII deficiency, mutations in the TCN2 gene mean the taxi is either never built or is built incorrectly [5][6]. This creates a confusing medical situation: the blood can be full of Vitamin B12, but the cells are essentially “starving” because the delivery system has failed [2].

How the Condition is Inherited

TCII deficiency is an autosomal recessive disorder. This means that for a child to have the condition, they must inherit two copies of the mutated TCN2 gene—one from each parent [7][8].

  • Carriers: Parents are typically “carriers,” meaning they have one mutated gene and one healthy gene. Carriers usually have no symptoms and no health problems related to TCII [8]. Parental diet did not cause this inherited transport defect.
  • The 25% Rule: When two carriers have a child, there is a 25% (1 in 4) chance with each independent pregnancy that the child will inherit both mutated genes and have the condition [8].
  • Genetic Counseling: Families should seek genetic counseling to discuss testing both parents, testing at-risk siblings, and exploring recurrence risks and reproductive options.

Why It Can Be Confusing to Diagnose

Because TCII deficiency affects the blood and the immune system, it often shares features with other serious conditions. Diagnosis requires an integrated biochemical, genetic, hematologic, and immunologic assessment.

1. Maternal B12 Deficiency

Many infants are flagged on newborn screens for elevated markers associated with B12, which can be due to the mother being deficient during pregnancy [9].

  • The Difference: Maternal B12 deficiency and TCII deficiency cannot reliably be distinguished by serum B12 alone, though in TCII deficiency, the blood B12 levels are usually normal or even high [2][3].

2. Myelodysplastic Syndrome (MDS)

MDS is a group of disorders where the bone marrow does not produce enough healthy blood cells. It can cause low red blood cells (anemia) and low white blood cells (neutropenia), just like TCII deficiency [7].

  • The Difference: While bone marrow samples in TCII deficiency might look like MDS, rapid improvement after high-dose B12 injections does not by itself rule out another marrow disorder. Genetic testing for the TCN2 gene provides the final confirmation [7].

3. Severe Combined Immunodeficiency (SCID)

SCID is a life-threatening primary immune disorder. Infants with TCII deficiency can have very low white blood cell counts and develop severe infections, making it an important consideration in the differential diagnosis [10][6].

  • The Difference: A specialized test called holotranscobalamin can support the finding that the active B12 “taxi” protein is missing, though it does not independently distinguish TCII deficiency from all other causes [11]. Urgent treatment and SCID precautions should not be delayed while waiting for a genetic result.

The Newborn Screening Signal

TCII deficiency is sometimes found incidentally during newborn screening for other metabolic conditions like Propionic Acidemia (PA) or Methylmalonic Aciduria (MMA) [9]. The screen looks for a marker called C3 (propionylcarnitine). Because TCII deficiency causes a backup in the same metabolic pathway, it can result in a “screen-positive” result with an elevated C3/C2 ratio [9][1].

An abnormal C3 result is not a “false alarm.” It has several possible causes, including propionic acidemia, methylmalonic disorders, cobalamin-processing disorders, and maternal B12 deficiency. It requires prompt confirmatory testing. Conversely, a normal screen cannot exclude TCII deficiency.

Common questions in this guide

What causes transcobalamin II (TCII) deficiency?
TCII deficiency is caused by disease-causing changes in the TCN2 gene, which makes the protein that carries vitamin B12 into cells. The resulting problem is B12 delivery and cellular use, not a lack of B12 in the diet.
How is TCII deficiency passed from parents to a child?
It follows an autosomal recessive pattern, so a child must inherit an altered TCN2 copy from each parent. Parents with one altered copy are usually healthy carriers; when both parents are carriers, each pregnancy has a 1-in-4 chance of being affected.
Can a normal or high vitamin B12 blood level still occur with TCII deficiency?
Yes. TCII deficiency prevents vitamin B12 from being delivered efficiently into cells, so the blood level may be normal or high even while cells lack usable B12. A serum B12 result alone cannot rule out the disorder.
Why can TCII deficiency be confused with SCID or MDS?
Affected infants may have low white or red blood cell counts and severe infections, which can also occur with severe combined immunodeficiency or myelodysplastic syndrome. Blood, immune, biochemical, bone marrow, and genetic testing may be needed, and urgent treatment or immune precautions should not wait for a genetic result when SCID is possible.
What does an elevated C3 result on a newborn screen mean?
An elevated C3 or C3/C2 ratio is a signal that needs prompt follow-up, not simply a false alarm. It can occur with TCII deficiency, propionic acidemia, methylmalonic disorders, other cobalamin-processing problems, or maternal B12 deficiency, so confirmatory testing is needed; a normal screen does not completely exclude TCII deficiency.
What does a holotranscobalamin test show?
Holotranscobalamin measures the active form of vitamin B12 carried by transcobalamin, the delivery protein. An abnormal result can support a problem with active B12 transport, but the test alone cannot distinguish TCII deficiency from every other cause of abnormal B12 handling.
Should parents and siblings have genetic testing for TCII deficiency?
Genetic counseling can help determine whether parents carry TCN2 variants, identify siblings who may be at risk, and discuss recurrence and reproductive options. Testing decisions should be based on the family’s specific genetic results and guidance from a genetics professional.

Get notified when new evidence is published on Transcobalamin deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    New data supporting that early diagnosis and treatment are possible and necessary in intracellular cobalamin depletion: the case of transcobalamin II deficiency.

    Verónica B, Crespo C, Lochner N, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2024; (37(4)):380-386 doi:10.1515/jpem-2023-0577.

    PMID: 38436354
  2. 2

    Transcobalamin II Deficiency in Four Cases with Novel Mutations.

    Ünal Ş, Rupar T, Yetgin S, et al.

    Turkish journal of haematology : official journal of Turkish Society of Haematology 2015; (32(4)):317-22 doi:10.4274/tjh.2014.0154.

    PMID: 25914105
  3. 3

    Unraveling the mystery: Exploring a case of prolonged fever and hidden genetics: Case report.

    Jamil SF, Alhawsawi KI, Alrefaei SM

    Journal of family medicine and primary care 2025; (14(5)):2065-2069 doi:10.4103/jfmpc.jfmpc_1839_24.

    PMID: 40547723
  4. 4

    Genetic polymorphisms of the cobalamin transport system are associated with idiopathic recurrent implantation failure.

    Park HS, Kim JO, An HJ, et al.

    Journal of assisted reproduction and genetics 2019; (36(7)):1513-1522 doi:10.1007/s10815-019-01455-4.

    PMID: 31123954
  5. 5

    A novel TCN2 mutation with unusual clinical manifestations of hemolytic crisis and unexplained metabolic acidosis: expanding the genotype and phenotype of transcobalamin II deficiency.

    Pongphitcha P, Sirachainan N, Khongkraparn A, et al.

    BMC pediatrics 2022; (22(1)):233 doi:10.1186/s12887-022-03291-5.

    PMID: 35488219
  6. 6

    Identification of transcobalamin deficiency with two novel mutations in the TCN2 gene in a Chinese girl with abnormal immunity: a case report.

    Zhan S, Cheng F, He H, et al.

    BMC pediatrics 2020; (20(1)):460 doi:10.1186/s12887-020-02357-6.

    PMID: 33023511
  7. 7

    Transcobalamin II deficiency mimicking myelodysplastic syndrome in a child: a case report.

    Hu X, Xu H, Xie L

    Frontiers in pediatrics 2026; (14()):1757303 doi:10.3389/fped.2026.1757303.

    PMID: 42038245
  8. 8

    "Progressive myoclonic ataxia and developmental/epileptic encephalopathy associated with a novel homozygous mutation in TCN2 gene".

    Oshi MAM, Alfaifi J, Alqahtani YAM, et al.

    Molecular genetics & genomic medicine 2024; (12(1)):e2282 doi:10.1002/mgg3.2282.

    PMID: 37800653
  9. 9

    Quantification of 2-methylcitric acid in dried blood spots improves newborn screening for propionic and methylmalonic acidemias.

    Al-Dirbashi OY, McIntosh N, Chakraborty P

    Journal of medical screening 2017; (24(2)):58-61 doi:10.1177/0969141316645824.

    PMID: 27216769
  10. 10

    Different Presentations of Patients with Transcobalamin II Deficiency: A Single-Center Experience from Turkey

    Ünal S, Karahan F, Arıkoğlu T, et al.

    Turkish journal of haematology : official journal of Turkish Society of Haematology 2019; (36(1)):37-42 doi:10.4274/tjh.galenos.2018.2018.0230.

    PMID: 30185401
  11. 11

    Neurological disorders in vitamin B12 deficiency.

    Pavlov CS, Damulin IV, Shulpekova YO, Andreev EA

    Terapevticheskii arkhiv 2019; (91(4)):122-129 doi:10.26442/00403660.2019.04.000116.

    PMID: 31094486

This page explains the inherited biology and diagnostic look-alikes of TCII deficiency for informational purposes only and does not constitute medical advice. A metabolic specialist, geneticist, and your child’s care team should interpret testing and guide treatment.